Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Wiss. Mitarbeiterinnen/Mitarbeiter, Klinik für Dermatologie
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
-
SoSe 2022
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Identification and characterization of tertiary lymphoid structures in brain metastasesIn: Acta Neuropathologica Communications, Jg. 13, 2025, Nr. 1, 91DOI (Open Access)
-
RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanomaIn: Clinical and Translational Medicine, Jg. 15, 2025, Nr. 1, e70094DOI (Open Access)
-
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaIn: British Journal of Dermatology: BJD, Jg. 192, 2025, Nr. 3, S. 481 – 491
-
Structure-based discovery of first inhibitors targeting the helicase activity of human PIF1In: Nucleic Acids Research, Jg. 52, 2024, Nr. 20, S. 12616 – 12632DOI (Open Access)
-
T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vesselsIn: Immunity, Jg. 57, 2024, Nr. 11, S. 2688 – 2703.e11DOI (Open Access)
-
Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain ColonizationIn: Cancer Research, Jg. 83, 2023, Nr. 8, S. 1299 – 1314DOI (Open Access)
-
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaIn: Nature Cancer, Jg. 4, 2023, Nr. 9, S. 1395DOI (Open Access)
-
ComplexEye : a multi-lens array microscope for high-throughput embedded immune cell migration analysisIn: Nature Communications, Jg. 14, 2023, Nr. 1, 8103DOI, Online Volltext (Open Access)
-
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaIn: Journal for ImmunoTherapy of Cancer, Jg. 11, 2023, Nr. 4, e004150DOI (Open Access)
-
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaIn: Nature Cancer, Jg. 4, 2023, Nr. 9, S. 1292 – 1308DOI (Open Access)
-
Rapid and fully automated blood vasculature analysis in 3D light-sheet image volumes of different organsIn: Cell Reports Methods, Jg. 3, 2023, Nr. 3, 100436DOI (Open Access)
-
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREGIn: Journal for ImmunoTherapy of Cancer, Jg. 10, 2022, Nr. 6, e004509DOI (Open Access)
-
Persister state-directed transitioning and vulnerability in melanoma
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Nature Communications, Jg. 13, 2022, Nr. 1, S. 35 – 36DOI, Online Volltext (Open Access) -
SIRT1‐mediated deacetylation of FOXO3a transcription factor supports pro‐angiogenic activity of interferon‐deficient tumor‐associated neutrophilsIn: International Journal of Cancer, Jg. 150, 2022, Nr. 7, S. 1198 – 1211DOI (Open Access)
-
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal, Jg. 43, 2022, Nr. 4, S. 316 – 329
-
Integrative genomic analyses of patient-matched intracranial and extracranial metastases reveal a novel brain-specific landscape of genetic variants in driver genes of malignant melanomaIn: Cancers, Jg. 13, 2021, Nr. 4, S. 731DOI, Online Volltext (Open Access)
-
Patient-derived human basal and cutaneous squamous cell carcinoma tissues display apoptosis and immunomodulation following gas plasma exposure with a certified argon jetIn: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 21, 11446DOI (Open Access)
-
Sequence‐Selective Covalent CaaX‐Box Receptors Prevent Farnesylation of Oncogenic Ras Proteins and Impact MAPK/PI3 K SignalingIn: ChemMedChem, Jg. 16, 2021, Nr. 16, S. 2504 – 2514DOI (Open Access)
-
Ex vivo exposure of human melanoma tissue to cold physical plasma elicits apoptosis and modulates inflammationIn: Applied Sciences, Jg. 10, 2020, Nr. 6, S. 1971DOI (Open Access)
-
Macrophages/microglia represent the major source of indolamine 2,3-dioxygenase expression in melanoma metastases of the brainIn: Frontiers in Immunology, Jg. 11, 2020, Article-No: 120DOI, Online Volltext (Open Access)
-
Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK Cell-Mediated Killing in MelanomaIn: Cancers, Jg. 11, 2019, Nr. 3, S. 356DOI, Online Volltext (Open Access)
-
Targeting the “undruggable” RAS - new strategies - new hope?In: Cancer Drug Resistance, Jg. 2, 2019, Nr. 3, S. 813 – 826DOI (Open Access)
-
Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative PlasticisersIn: International Journal of Molecular Sciences (IJMS), Jg. 19, 2018, Nr. 4, S. 1133DOI (Open Access)
-
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growthIn: Nature Communications, Jg. 8, 2017, S. 14600DOI (Open Access)
-
Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regressionIn: Nature Communications, Jg. 8, 2017, S. 14447DOI (Open Access)
-
Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanomaIn: European Journal of Cancer (EJC), Jg. 59, 2016, S. 109 – 112
-
Role of Acid Sphingomyelinase-Induced Signaling in Melanoma Cells for Hematogenous Tumor MetastasisIn: Cellular Physiology and Biochemistry, Jg. 38, 2016, Nr. 1, S. 1 – 14DOI (Open Access)
-
Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexiaIn: Nature Communications, Jg. 7, 2016, S. 12528DOI (Open Access)
-
Tension in CancerIn: International Journal of Molecular Sciences (IJMS), Jg. 17, 2016, Nr. 11, S. 1910DOI, Online Volltext (Open Access)
-
CEACAM1-3S drives melanoma cells into NK cell-mediated cytolysis and enhances patient survivalIn: Cancer Research, Jg. 75, 2015, Nr. 9, S. 1897 – 1907DOI (Open Access)
-
CEACAM1-4L promotes anchorage-independent growth in melanomaIn: Frontiers in Oncology, Jg. 5, 2015, 234DOI (Open Access)
-
Clinical application of noninvasive and nonradioactive determination of microscopic lymph node tumor status by multispectral optoacoustic imagingIn: Journal of Nuclear Medicine (JNM), Jg. 56, 2015, Nr. Suppl. 3, S. 40
-
Die multispektraloptoakustische Tomographie (MSOT) zur nichtinvasiven Diagnostik des Schildwächterlymphknotens bei Patienten mit malignem MelanomIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 13, 2015, Nr. 12, S. 1323
-
MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanomaIn: Pigment Cell and Melanoma Research, Jg. 28, 2015, Nr. 6, S. 736 – 740
-
Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imagingIn: Immunotherapy, Jg. 7, 2015, Nr. 317, S. 317ra199
-
Regulation of hematogenous tumor metastasis by acid sphingomyelinaseIn: EMBO Molecular Medicine, Jg. 7, 2015, Nr. 6, S. 714 – 734DOI (Open Access)
-
Die Photooptoakustische Tomographie zur nicht invasiven und nicht radioaktiven Bestimmung des Schildwachterlymphknotenstatus bei MelanompatientenIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 12, 2014, Nr. Suppl. 3, S. 5 – 6
-
Isoform-specific function of CEACAM1 during tumorigenesis : CEACAM1-3S, a novel prognostic biomarker in malignant melanomaIn: Experimental Dermatology, Jg. 23, 2014, Nr. 3, S. E45
-
Primary tumor versus metastasis : new experimental models for studies on cancer cell homing and metastasis in melanomaIn: Pigment Cell and Melanoma Research, Jg. 27, 2014, Nr. 2, S. 309 – 316
-
The impact of the immune system on tumor : angiogenesis and vascular remodelingIn: Frontiers in Oncology, Jg. 4, 2014, S. 69DOI (Open Access)
-
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanomaIn: Nature, Jg. 507, 2014, Nr. 7490, S. 109 – 113
-
Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cellsIn: Arteriosclerosis, Thrombosis, and Vascular Biology, Jg. 33, 2013, Nr. 7, S. 1561 – 1567
-
Neuropilin-1 is a key mediator of VEGF-dependent Treg migration to tumorsIn: International Journal of Molecular Medicine, Jg. 32, 2013, Nr. Suppl. 1, S. S36
-
Vascular endothelial growth factor promotes pericyte coverage of brain capillaries, improves cerebral blood flow during subsequent focal cerebral ischemia, and preserves the metabolic penumbraIn: Stroke, Jg. 44, 2013, Nr. 6, S. 1690 – 1697
-
Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosisIn: Blood, Jg. 119, 2012, Nr. 24, S. 5931 – 5942
-
Neuropilin 1 deficiency on CD4⁺Foxp3⁺ regulatory T cells impairs mouse melanoma growthIn: Journal of Experimental Medicine (JEM), Jg. 209, 2012, Nr. 11, S. 2001 – 2016DOI (Open Access)
-
A wound size-dependent effect of myeloid cell-derived vascular endothelial growth factor on wound healingIn: Journal of Investigative Dermatology, Jg. 131, 2011, Nr. 3, S. 797 – 801DOI (Open Access)
-
Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma : One step forward for overcoming anti-angiogenic drug resistance?In: Molecular Oncology, Jg. 5, 2011, Nr. 2, S. 137 – 149
-
The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cellsIn: Blood, Jg. 117, 2011, Nr. 9, S. 2735 – 2744DOI, Online Volltext (Open Access)
-
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanomaIn: Journal of Experimental Medicine (JEM), Jg. 207, 2010, Nr. 3, S. 491 – 503DOI (Open Access)
-
1384 Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy and significantly increases B-cell response in syngeneic liver Hepa1-6 tumor microenvironmentIn: Journal for ImmunoTherapy of Cancer. London: BMJ, Jg. 10, 2022, Nr. Suppl. 2DOI (Open Access)
-
Compartment-based proteomics of CD8high vs. CD8low melanoma regions reveals differential regulation of TOR signaling
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 12 -
Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 41, 2020, Nr. Supplement_2, S. 3260DOI (Open Access) -
Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 41, 2020, Nr. Supplement_2, S. 3250DOI (Open Access) -
Catch me if you can! : Novel immune escape mechanisms in melanoma metastases of the brain
45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,In: Experimental Dermatology. Hoboken: Wiley, Jg. 27, 2018, Nr. 3, S. e15DOI (Open Access) -
P6552 C57BL/6 programmed death 1 deficient mice show myocardial antibody deposits but preserved functional integrity of the cardiovascular system
ESC Congress 2018 25 - 29 August Munich, Germany,In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 39, 2018, Nr. suppl_1, S. 1399 -
Potential role of TGF-beta signaling in immune-checkpoint-therapy-induced resistance in malignant melanoma
45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; March 7‐10, 2018, Zürich,In: Experimental Dermatology. Hoboken: Wiley, Jg. 27, 2018, Nr. 3, S. e63 – e64DOI (Open Access) -
Neuropilin-1 Deficiency on CD4+Foxp3+Regulatory T Cells Modulates Tumor Angiogenesis and Impaires Tumor Growth in MelanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 11, 2013, Nr. Suppl. S7, S. 30
-
Neuropilin-1 mediates infiltration of regulatory T cells into tumors favoring immune escapeIn: European Journal of Immunology. Hoboken: Wiley, Jg. 190, 2013, S. P2063
-
Persister state-directed transitioning and vulnerability in melanoma
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 20, 2022, Nr. S3, S. 35 – 36